Clinical Trial Details

EORTC-1221-ETF

Back to Clinical Trials Database

Cancer in elderly nursing home residents in Belgium: prospective cohort study including translational research to develop better prognostic tools to help with treatment decisions in the elderly

Study documentation

Trial Status LT-FU ongoing
Dates Date of activation: 27-Nov-2014
Date Step1 close: 22-Dec-2017
Data management at EORTC Yes
Design Cohort
Not randomized / N.A.
Targeted Sample size EORTC Groups: 825 - All Groups: 825
Treatment
Study Staff Hans P.M.W. Wildiers (Study Coordinator) , U.Z. Leuven - Campus Gasthuisberg, Leuven
Melanie Beauvois (Clinical Operations Manager) , EORTC Headquarters, Brussels
Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels
Murielle Mauer (Statistician) , EORTC Headquarters, Brussels
Nabila Sebti (Data Manager) , EORTC Headquarters, Brussels
Type of cancer
Participating groups EORTC Cancer in Elderly Task Force
Recruiting centers Binnenhof (Merksplas, Belgium)
Dageraad (Antwerpen, Belgium)
De Neuwe Seigneurie (Rumbeke, Belgium)
De Notelaar (Olen, Belgium)
De Wyngaert (Rotselaar, Belgium)
Gaerveld (Hasselt, Belgium)
Groenveld (Wilrijk, Belgium)
Heiberg (Beerse, Belgium)
Hemelrijk (Mol, Belgium)
Hestia (Wemmel, Belgium)
Heydehof (Hoboken, Belgium)
Hof Ter Dennen (Vosselaar, Belgium)
Home Castel (Jette, Belgium)
Home Floréal (Zottegem, Belgium)
Home Sebrechts (Brussels, Belgium)
L'Oree du bois (Warneton, Belgium)
La Douce Quiétude (Marche-en-Famenne, Belgium)
La Pairelle (Wépion, Belgium)
Laarsveld (Geel, Belgium)
Larenshof (Laarne, Belgium)
Le Lothier (Genappe, Belgium)
Le Ménil (Braine l'Alleud, Belgium)
Les 3 couronnes (Esneux, Belgium)
Les Charmes en Famenne (Mesnil-Saint-Blaise, Belgium)
Mathelin (Messancy, Belgium)
Millegem (Ranst, Belgium)
Nethehof (Balen, Belgium)
Orchidee (Ittre, Belgium)
Overbeke (Wetteren, Belgium)
Pagode (Brussels, Belgium)
Plantijn (Kapellen, Belgium)
Pont d'amour (Dinant, Belgium)
Residentie Den Brem (Rijkevorsel, Belgium)
Rietdijk (Vilvoorde, Belgium)
Résidence Balmoral (Ixelles, Belgium)
Résidence du parc (Grez-Doiceau, Belgium)
Salve (Brasschaat, Belgium)
Smeedeshof (Oud-Turnhout, Belgium)
Spanjeberg (Asse, Belgium)
Ter Venne (Sint-Martens-Latem, Belgium)
Val Mosan (Liège, Belgium)
Vogelzang (Herentals, Belgium)
Vondelhof (Boutersem, Belgium)
Voortberg (Testelt, Belgium)
Wommelgheem (Wommelgheem, Belgium)
Protocol summary http://clinicaltrials.gov/study/NCT01910376
NCT number NCT01910376
Financial Support External Grant